Latest News for: Study cgi

Edit

Newron presents 2024 financial results and provides 2025 outlook

Pharmiweb 01 Apr 2025
the primary endpoint (improvement of the Positive and Negative Syndrome Scale PANSS Total Score) and key secondary endpoint (improvement of the Clinical Global Impression of Severity CGI-S), with a 96% rate of study completion.
  • 1
×